tirzepatide pregnancy risks What are the of becoming pregnant while taking (glucagon-like peptide-1 receptor agonist)? Tirzepatide & Pregnancy: Safety Facts
Description
Tirzepatide (Mounjaro and Zepbound) pregnancies fall under the same umbrella
For example, the addition of semaglutide at a dose of 0.5 mg or 1 mg per week in patients receiving basal insulin resulted in a 1% and 1.8% decrease in HbA1c, respectively, in SUSTAIN- 5
What am I getting: 1-month supply of compounded tirzepatide
Clinical trials have reported gastrointestinal side effects as common adverse events with incretin-based therapies, including nausea and vomiting, which may affect patient adherence
Retatrutide is not FDA-approved and cannot be obtained through standard prescriptions
